IL164613A0 - Thienyl compounds - Google Patents
Thienyl compoundsInfo
- Publication number
- IL164613A0 IL164613A0 IL16461304A IL16461304A IL164613A0 IL 164613 A0 IL164613 A0 IL 164613A0 IL 16461304 A IL16461304 A IL 16461304A IL 16461304 A IL16461304 A IL 16461304A IL 164613 A0 IL164613 A0 IL 164613A0
- Authority
- IL
- Israel
- Prior art keywords
- compounds
- thienyl compounds
- thienyl
- compositions
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201187A SE0201187D0 (sv) | 2002-04-18 | 2002-04-18 | Thienyl compounds |
SE0203608A SE0203608D0 (sv) | 2002-12-04 | 2002-12-04 | Thienyl compounds |
PCT/SE2003/000614 WO2003087103A1 (en) | 2002-04-18 | 2003-04-15 | Thienyl compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL164613A0 true IL164613A0 (en) | 2005-12-18 |
Family
ID=29253789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16461304A IL164613A0 (en) | 2002-04-18 | 2004-10-14 | Thienyl compounds |
Country Status (17)
Country | Link |
---|---|
US (3) | US7186836B2 (zh) |
EP (1) | EP1499615B1 (zh) |
JP (1) | JP4511196B2 (zh) |
KR (1) | KR20040099448A (zh) |
CN (1) | CN1325499C (zh) |
AT (1) | ATE477256T1 (zh) |
AU (1) | AU2003224545B2 (zh) |
BR (1) | BR0309342A (zh) |
CA (1) | CA2482312A1 (zh) |
DE (1) | DE60333746D1 (zh) |
ES (1) | ES2348282T3 (zh) |
HK (1) | HK1079522A1 (zh) |
IL (1) | IL164613A0 (zh) |
MX (1) | MXPA04010193A (zh) |
NO (1) | NO20044997L (zh) |
NZ (1) | NZ535978A (zh) |
WO (1) | WO2003087103A1 (zh) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
HUP0402289A2 (hu) | 2001-10-02 | 2005-02-28 | Pharmacia & Upjohn Company | Gyógyhatású azabiciklusos csoporttal helyettesített kondenzált heteroaril-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
BR0309342A (pt) * | 2002-04-18 | 2005-02-15 | Astrazeneca Ab | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas |
AU2003225456B2 (en) * | 2002-04-18 | 2009-02-05 | Astrazeneca Ab | Furyl compounds |
KR20060094962A (ko) * | 2003-10-21 | 2006-08-30 | 아스트라제네카 아베 | 스피로푸로피리딘 아릴 유도체 |
US7045530B2 (en) | 2003-12-22 | 2006-05-16 | Abbott Laboratories | Spirocyclic quinuclidinic ether derivatives |
TW200813067A (en) * | 2006-05-17 | 2008-03-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
SA08290475B1 (ar) * | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
ME01516B (me) | 2008-06-20 | 2014-04-20 | Astrazeneca Ab | DERIVAT DIBENZOTIAZEPINA l NJEGOVA UPOTREBA |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
CN105837566B (zh) | 2010-05-17 | 2018-02-06 | 富瑞姆制药公司 | (R)‑7‑氯‑N‑(奎宁环‑3‑基)苯并[b]噻吩‑2‑甲酰胺盐酸盐单水合物的晶型 |
GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
EP2846796A4 (en) | 2012-05-08 | 2015-10-21 | Forum Pharmaceuticals Inc | METHODS OF MAINTAINING, PROCESSING OR ENHANCING COGNITIVE FUNCTION |
GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
ES2694299T3 (es) | 2013-02-07 | 2018-12-19 | Heptares Therapeutics Limited | Carboxilatos de piperidin-1-ilo y azepin-1-ilo como agonistas del receptor muscarínico M4 |
CA2914263C (en) | 2013-06-21 | 2021-05-18 | Takeda Pharmaceutical Company Limited | 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors |
GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
CN112898312B (zh) * | 2021-01-29 | 2021-11-12 | 湖南南新制药股份有限公司 | 一种稠合多环吡啶酮衍生物及其用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
SE9900100D0 (sv) * | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
FR2788982B1 (fr) | 1999-02-02 | 2002-08-02 | Synthelabo | Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique |
US20010016677A1 (en) * | 1999-02-16 | 2001-08-23 | Dan Russell Poole | Incubator with thermoelectric cooler |
US6569865B2 (en) * | 2001-06-01 | 2003-05-27 | Astrazeneca Ab | Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine |
IL158735A0 (en) * | 2001-06-01 | 2004-05-12 | Astrazeneca Ab | Novel ligand for nicotinic acetylcholine receptors useful in therapy |
AU2003225456B2 (en) * | 2002-04-18 | 2009-02-05 | Astrazeneca Ab | Furyl compounds |
BR0309342A (pt) * | 2002-04-18 | 2005-02-15 | Astrazeneca Ab | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas |
-
2003
- 2003-04-15 BR BR0309342-5A patent/BR0309342A/pt not_active IP Right Cessation
- 2003-04-15 WO PCT/SE2003/000614 patent/WO2003087103A1/en active Application Filing
- 2003-04-15 MX MXPA04010193A patent/MXPA04010193A/es active IP Right Grant
- 2003-04-15 AU AU2003224545A patent/AU2003224545B2/en not_active Expired - Fee Related
- 2003-04-15 AT AT03721208T patent/ATE477256T1/de not_active IP Right Cessation
- 2003-04-15 CA CA002482312A patent/CA2482312A1/en not_active Abandoned
- 2003-04-15 EP EP03721208A patent/EP1499615B1/en not_active Expired - Lifetime
- 2003-04-15 CN CNB038137828A patent/CN1325499C/zh not_active Expired - Fee Related
- 2003-04-15 ES ES03721208T patent/ES2348282T3/es not_active Expired - Lifetime
- 2003-04-15 US US10/511,522 patent/US7186836B2/en not_active Expired - Fee Related
- 2003-04-15 KR KR10-2004-7016548A patent/KR20040099448A/ko not_active Application Discontinuation
- 2003-04-15 NZ NZ535978A patent/NZ535978A/en unknown
- 2003-04-15 DE DE60333746T patent/DE60333746D1/de not_active Expired - Lifetime
- 2003-04-15 JP JP2003584059A patent/JP4511196B2/ja not_active Expired - Fee Related
-
2004
- 2004-10-14 IL IL16461304A patent/IL164613A0/xx unknown
- 2004-11-17 NO NO20044997A patent/NO20044997L/no not_active Application Discontinuation
-
2005
- 2005-12-16 HK HK05111638A patent/HK1079522A1/xx not_active IP Right Cessation
-
2007
- 2007-01-29 US US11/668,099 patent/US20070142419A1/en not_active Abandoned
-
2010
- 2010-10-27 US US12/912,840 patent/US20110124672A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1499615A1 (en) | 2005-01-26 |
CN1659170A (zh) | 2005-08-24 |
NZ535978A (en) | 2007-10-26 |
AU2003224545B2 (en) | 2009-08-13 |
HK1079522A1 (en) | 2006-04-07 |
ATE477256T1 (de) | 2010-08-15 |
DE60333746D1 (de) | 2010-09-23 |
US20070142419A1 (en) | 2007-06-21 |
US7186836B2 (en) | 2007-03-06 |
EP1499615B1 (en) | 2010-08-11 |
CA2482312A1 (en) | 2003-10-23 |
US20110124672A1 (en) | 2011-05-26 |
JP2005527588A (ja) | 2005-09-15 |
NO20044997L (no) | 2005-01-18 |
WO2003087103A1 (en) | 2003-10-23 |
ES2348282T3 (es) | 2010-12-02 |
AU2003224545A1 (en) | 2003-10-27 |
JP4511196B2 (ja) | 2010-07-28 |
KR20040099448A (ko) | 2004-11-26 |
MXPA04010193A (es) | 2005-02-03 |
BR0309342A (pt) | 2005-02-15 |
CN1325499C (zh) | 2007-07-11 |
US20050171106A1 (en) | 2005-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1079522A1 (en) | Thienyl compounds | |
HK1080470A1 (en) | Heterocyclic compounds | |
HK1079519A1 (en) | Furyl compounds | |
SE0202463D0 (sv) | Novel compounds | |
MY134568A (en) | Cb2 receptor agonists | |
PL372926A1 (en) | Piperidine-pyridazones and phthalazones as pde4 inhibitors | |
MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
GB0114286D0 (en) | Nucleoside Derivatives | |
MX2007005933A (es) | Compuestos de acetamida como fungicidas. | |
AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
SE0401971D0 (sv) | Piperidne derivatives | |
TW200643013A (en) | Pyrazoles | |
IL173810A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
SE0401970D0 (sv) | Novel compounds | |
UA86776C2 (ru) | Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение | |
SE0301320D0 (sv) | Positive modulators of nicotinic acetylcholine receptors | |
TW200626581A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
IL173809A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
IL173895A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
GB0229081D0 (en) | Multifunctional cationic photoinitiators, their preparation and use | |
HK1091816A1 (en) | Diphenylurea derivatives and their use as chloride channel blockers | |
MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
MXPA06003345A (es) | Derivados de aminopiridina como inhibidores de la no-sintasa inducible. | |
GB0212410D0 (en) | Organic compounds | |
MXPA05006957A (es) | Nuevos derivados de fosforamida. |